Cell and Gene Therapy for Personalised Medicine
The European Partnership for Personalised Medicine (EP PerMed) is soliciting applications for the Joint Transnational Call (JTC) 2027.
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapy (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
At least one of the following approaches must be employed:
• Somatic cell therapeutics;
• Gene therapeutics;
• Combined cell- and gene therapeutics;
• Novel biological products such as mRNA, other nucleic acid-based methods, and extracellular vesicles as vehicle for gene-based therapeutic procedure.
Research projects in all disease areas are encouraged.
An online information day will be held on 3.12.2026.
A partnering tool is available for the call.
הגשת קדם הצעות עד 20.1.2027.